Metformin Use in PCOS Patients During Pregnancy
Introduction to Metformin in Pregnancy
- The American College of Obstetricians and Gynecologists recommends that metformin should be discontinued once pregnancy is confirmed in women with PCOS, as there is no evidence-based need to continue it during pregnancy, and long-term safety data show concerning trends including higher BMI and increased obesity rates in children exposed to metformin in utero 1, 2
Key Evidence Against Continuation in Pregnancy
- Randomized, double-blind, controlled trials comparing metformin with other therapies for ovulation induction in women with PCOS have demonstrated no benefit in preventing spontaneous abortion or gestational diabetes once pregnancy has been confirmed 1
- The American College of Obstetricians and Gynecologists explicitly states there is no evidence-based need to continue metformin in PCOS patients once pregnancy has been confirmed 1
Placental Transfer and Offspring Concerns
- Metformin readily crosses the placenta, with umbilical cord blood levels equal to or higher than maternal levels 2
- Long-term offspring data show concerning trends, including higher BMI, increased waist circumference, higher waist-to-height ratios, and increased obesity rates in children exposed to metformin in utero 2, 3
Clinical Algorithm for PCOS Patients on Metformin
- The American College of Obstetricians and Gynecologists recommends that metformin should not be used in pregnant women with hypertension, preeclampsia, or those at risk for intrauterine growth restriction 3
- Discontinue metformin immediately once pregnancy test is positive, and transition to pregnancy-appropriate management for glucose control if needed (insulin is the preferred agent for diabetes management in pregnancy) 1